Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses

Viral pathogens continue to constitute a heavy burden on healthcare and socioeconomic systems. Efforts to create antiviral drugs repeatedly lag behind the advent of pathogens and growing understanding is that broad‐spectrum antiviral agents will make strongest impact in future antiviral efforts. Thi...

Ausführliche Beschreibung